Studies

Comprehensive biomarker studies supported by febit

febit’s service options offer full support for successful biomarker discovery, screening approaches and validation processes.

With ABI SOLiD next generation sequencing for discovery, the established Geniom microarray technology for screening, and TaqMan quantitative RT-PCR for validation, febit is the ideal partner for your biomarker studies.

Genomic Services

A growing list of biomarker studies covering 13 major diseases, e.g. lung cancer [1] and Multiple Sclerosis [2], have already been successfully accomplished.

1 Keller A et al. BMC Cancer. 2009 Oct 6;9:353
2 Keller A et al. PLoS One. 2009 Oct 13;4(10):e7440

The goal of such biomarker studies is to

• develop diagnostic and prognostic biomarker signatures
• detect human diseases such as cancer at an early stage
• optimize treatment with personalized patient care